Yueda biological new third board listing main plant extract research and development
-
Last Update: 2015-12-26
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On December 25, Xi'an Yueda Biotechnology Co., Ltd (Securities abbreviation: Yueda bio securities code: 834891) listed for public transfer in the national stock transfer system by means of agreement transfer According to the announcement, Yueda biological's operating revenue in 2013 and 2014 was 7.0993 million yuan, 9.3579 million yuan and 5.6964 million yuan respectively, and its net profit was 445100 yuan, 88100 yuan and 291000 yuan respectively Yueda biology was founded on March 26, 2009 Its main business is the research and development, production and sales of plant extracts The company mainly produces different specifications of plant extract products through the fine processing of crude plant extract products, which are supplied to the production enterprises and intermediate traders in the food, health care products, pharmaceutical industry and other customers The sponsor of this listing application is Western securities Sigmar accounting firm (special general partnership) is responsible for financial audit, and Beijing Dacheng (Xi'an) law firm is the special legal adviser.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
